GCC And UAE Diabetes Devices Market

GCC And UAE Diabetes Devices Market Size, Share, Growth Analysis, By Services(Devices And Wearables, Pharma), By End-Use(Hospitals, Homecare), By Country(Saudi Arabia, UAE) - Industry Forecast 2024-2031


Report ID: UCMIR35A2604 | Region: Regional | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

GCC And UAE Diabetes Devices Market Insights

Market Overview:

The diabetes devices market in the GCC (Gulf Cooperation Council) and UAE (United Arab Emirates) region was estimated to be worth USD 2.76 billion in 2022. Over the forecast period from 2023 to 2030, it is projected to experience a steady growth rate of 7.1% annually. This growth can be attributed to several factors, including the rising prevalence of diabetes, increasing awareness about the condition, and advancements in diabetes management technologies. As the region continues to witness lifestyle changes and an aging population, the demand for diabetes devices such as glucose monitoring systems, insulin delivery devices, and other related equipment is expected to surge. This expanding market presents significant opportunities for both domestic and international manufacturers operating in the GCC and UAE.

GCC And UAE Diabetes Devices Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for GCC And UAE Diabetes Devices was estimated to be valued at US$ XX Mn in 2021.

The GCC And UAE Diabetes Devices Market is estimated to grow at a CAGR of XX% by 2028.

The GCC And UAE Diabetes Devices Market is segmented on the basis of Services, End-Use, Country.

Based on region, the GCC And UAE Diabetes Devices Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the GCC And UAE Diabetes Devices Market are Medtronic, Abbot Laboratories, Ascensia Diabetes Care Holdings, Dexcom, F. Hoffmann- La Roche AG,, Sanofi, Novo Nordisk A/S, Insulet Corporation, Ypsomed AG, Eli Lily, Astra Zeneca.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

GCC And UAE Diabetes Devices Market

Product ID: UCMIR35A2604

$5,300
BUY NOW GET FREE SAMPLE